Monarch Partners Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$4.16M Sell
2022
Q3
$5.13M Buy
2022
Q2
$4.16M Buy
2016
Q4
Sell
2016
Q3
$3.5M Buy